(0.12%) 5 254.55 points
(0.05%) 39 779 points
(0.03%) 16 404 points
(1.65%) $82.69
(0.58%) $1.728
(0.98%) $2 234.40
(0.65%) $24.91
(1.37%) $922.15
(0.28%) $0.926
(0.71%) $10.84
(0.08%) $0.792
(0.22%) $92.64
@ $13.37
Issued: 14 Feb 2024 @ 14:08
Return: 21.29%
Previous signal: Feb 13 - 10:35
Previous signal:
Return: 0.00 %
Live Chart Being Loaded With Signals
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States...
Stats | |
---|---|
Today's Volume | 212 449 |
Average Volume | 1.51M |
Market Cap | 1.91B |
EPS | $0 ( 2024-03-20 ) |
Next earnings date | ( $0.360 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 25.73 |
ATR14 | $0.0180 (0.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-15 | Del Carmen Jeffrey | Sell | 10 667 | Restricted Stock Units |
2024-02-15 | Del Carmen Jeffrey | Buy | 10 667 | Common stock, par value $0.001 per share |
2024-02-15 | Del Carmen Jeffrey | Sell | 3 125 | Common stock, par value $0.001 per share |
2024-02-15 | Daly Richard J | Sell | 4 000 | Restricted Stock Units |
2024-02-15 | Daly Richard J | Buy | 4 000 | Common stock, par value $0.001 per share |
INSIDER POWER |
---|
39.33 |
Last 100 transactions |
Buy: 3 305 962 | Sell: 1 428 545 |
Volume Correlation
Catalyst Pharmaceuticals Correlation
10 Most Positive Correlations | |
---|---|
PMTS | 0.897 |
KPTI | 0.88 |
AVID | 0.873 |
PRAA | 0.854 |
FCCO | 0.852 |
BNIXU | 0.849 |
PINC | 0.848 |
KTCC | 0.844 |
PARA | 0.843 |
DTEA | 0.838 |
10 Most Negative Correlations | |
---|---|
CVGI | -0.927 |
CRSP | -0.915 |
NNOX | -0.915 |
POWL | -0.914 |
ADMS | -0.914 |
FTDR | -0.912 |
MDXG | -0.912 |
FLGC | -0.905 |
CNCE | -0.905 |
RESN | -0.904 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Catalyst Pharmaceuticals Correlation - Currency/Commodity
Catalyst Pharmaceuticals Financials
Annual | 2023 |
Revenue: | $398.20M |
Gross Profit: | $313.67M (78.77 %) |
EPS: | $0.670 |
Q4 | 2023 |
Revenue: | $110.57M |
Gross Profit: | $85.70M (77.51 %) |
EPS: | $0.330 |
Q3 | 2023 |
Revenue: | $102.69M |
Gross Profit: | $88.52M (86.20 %) |
EPS: | $-0.290 |
Q2 | 2023 |
Revenue: | $99.58M |
Gross Profit: | $87.54M (87.90 %) |
EPS: | $0.360 |
Financial Reports:
No articles found.
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators